Copegus and Mobic drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Copegus (ribavirin) and Mobic (meloxicam). Common drug interactions include anaemia among females and ankle fracture among males.
The phase IV clinical study analyzes what interactions people have when they take Copegus and Mobic. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Copegus?
Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.
What is Mobic?
Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.
11 people who take Copegus and Mobic together, and have interactions are studied.

What are the common drug interactions of Copegus and Mobic, by gender? *:
female:
- Anaemia (lack of blood)
- Blood glucose increased
- Chills (felling of cold)
- Myalgia (muscle pain)
- Pyrexia (fever)
- Benign ovarian tumour
- Blood pressure increased
- Gallbladder disorder
- Gout (uric acid crystals building up in the body)
- Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
male:
- Ankle fracture
- Cellulitis (infection under the skin)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Increased upper airway secretion
- Joint dislocation (a joint position is changed from normal position)
- Local swelling (swelling at the site of some application of substance or injury)
- Oedema peripheral (superficial swelling)
- Oropharyngeal pain
- Peripheral swelling
- Red blood cell count decreased
What are the common drug interactions of Copegus and Mobic, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Anaemia (lack of blood)
- Blood glucose increased
- Chills (felling of cold)
- Myalgia (muscle pain)
- Pyrexia (fever)
- Agitation (state of anxiety or nervous excitement)
- Arthralgia (joint pain)
- Depression
- Drug ineffective
- Dyspnoea exertional (breathlessness or shortness of breath)
50-59:
- Joint effusion (presence of extra fluid in joint covering)
- White blood cell count decreased
- Colon cancer
- Cough
- Drug ineffective
- Dysphagia (a condition in which swallowing is difficult or painful)
- Increased upper airway secretion
- Joint dislocation (a joint position is changed from normal position)
- Local swelling (swelling at the site of some application of substance or injury)
- Oedema peripheral (superficial swelling)
60+:
- Blood pressure increased
- Gout (uric acid crystals building up in the body)
- Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
What are the existing conditions these people have? *
- High Blood Pressure: 4 people, 36.36%
- Depression: 3 people, 27.27%
- Asthma: 2 people, 18.18%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 18.18%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 18.18%
- Depressive Symptom: 2 people, 18.18%
- Multiple Allergies (allergy to multiple agents): 2 people, 18.18%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
- Back Pain: 1 person, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Copegus and Mobic?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Copegus and Mobic:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Copegus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mobic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Copegus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mobic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on ribavirin and meloxicam (the active ingredients of Copegus and Mobic, respectively), and Copegus and Mobic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Magnesium Oxide cause Pulse Absent? - now
- Could Folate cause Protein - Urine? - a second ago
- Could Magnesium Oxide cause Performance Status Decreased? - 3 seconds ago
- Drug interactions of Estrace and Rytary - 9 seconds ago
- Could Avalide cause Numbness And Tingling? - 9 seconds ago
- Drug interactions of Estrace and Alprazolam - 10 seconds ago
- Marcaine vs. Methotrexate, side effect and effectiveness comparison - 16 seconds ago
- Drug interactions of Tranexamic Acid and Palonosetron - 20 seconds ago
- Drug interactions of Methylphenidate Hydrochloride and Abilify - 24 seconds ago
- Drug interactions of Dutasteride and Esbriet - 31 seconds ago